印度格列卫价格 新版（A new edition of Indias gleevec price）.docVIP

印度格列卫价格 新版（A new edition of Indias gleevec price） Common name: Imatinib Mesylate (India NATCO company called VEENAT. Commonly known as: Indian gleevec) scientific name: VEENAT English name: Imatinib Mesylate Capsules specification: 120 / bottle of Chinese pinyin: Jiahuangsuan Yimatini Jiaonang for VEENAT is India NATCO company production, in China there is no food and drug administration approval, so for illegal drugs in China, the encyclopedia for comments only. The following is an introduction to gleevec, not the introduction of VEENAT, which is known as the unwitting user. [1] Gleevec is a new generation of targeted anti-cancer drugs that have inhibitory effects on platelet source growth factor (PDGF) receptor protein kinase. Gleevec is one of the best of all anti-tumor drugs. Gleevec is more effective than 94% in new diagnosis of chronic myelogenous leukemia (CML), and 76% of patients can get cytological remission. The packaging of gleevec (imatinib) is 120 tablets, each containing 119.45 mg of imatinib, equivalent to 100mg of imatinib. Medicines are bottled in white polyethylene. The third phase of clinical trial results show that gleevec for newly diagnosed with chronic myeloid leukemia (CML) treatment efficiency more than 94%, and 76% of the patients can get cytology, stage of accelerating and snap of efficient also reached 71% and 71% respectively. Gleevec also has an effective rate of 67 per cent in gastrointestinal stromal tumors. Indications: Gleevec (imatinib) is used to treat chronic adult chronic myelogenous leukemia in a new diagnosis of Philadelphia chromosome positive (Ph +). Gleevec (imatinib mesylate) used in the treatment of Philadelphia chromosome positive in a radically increasing stage and accelerating stage of chronic myelogenous leukemia, mesylate imatinib is also used to treat has been treated with interferon in chronic phase CML. Gleevec is also used to treat chronic myelogenous leukemia in children with a recurrence of bone marrow and tre